Morgan Jody, Jones Alison, Kelso Celine
Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.
Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Intern Med J. 2021 Jul;51(7):1156-1159. doi: 10.1111/imj.15412.
The Australian Government recently walked away from changes to the importation of nicotine-containing electronic cigarette fluids, originally due to come into force on 1 January 2021. Additionally, the Therapeutic Goods Administration is in the process of rescheduling nicotine for use in e-fluids. We are concerned that the 270 000 daily vapers in Australia will purchase high concentrations of nicotine (≥100 mg/mL) for mixing with nicotine-free locally purchased e-fluids, which is a pathway of increased relative harm. We would like to see regulation of these products to limit the maximum concentration of nicotine, ensure appropriate child-resistant containers and compulsory labelling for all nicotine-containing e-fluid bottles.
澳大利亚政府最近放弃了对含尼古丁电子烟液进口规定的修改，这些修改原定于2021年1月1日生效。此外，治疗用品管理局正在重新安排尼古丁在电子烟液中的使用分类。我们担心，澳大利亚每天27万的电子烟使用者会购买高浓度尼古丁（≥100毫克/毫升）来与在当地购买的无尼古丁电子烟液混合，这是一种会增加相对危害的途径。我们希望看到对这些产品进行监管，以限制尼古丁的最大浓度，确保使用合适的防儿童开启容器，并对所有含尼古丁的电子烟液瓶进行强制标注。
